E
VentriPoint Diagnostics Ltd. VPT.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 11.60% 3.34% 0.44% -6.61% 0.29%
Total Depreciation and Amortization -8.54% -9.20% -6.90% -6.18% 2.56%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 211.26% 118.53% 39.13% 24.40% -57.26%
Change in Net Operating Assets 44.77% 83.10% 51.87% 311.03% 3,460.90%
Cash from Operations 43.71% 27.10% 12.24% 6.01% 2.16%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 18.76% -- -- -- --
Total Debt Repaid 22.92% 24.81% -53.91% -79.50% -114.84%
Issuance of Common Stock 3,113.30% 2,199.47% -- 999.64% -61.79%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -256.40% -- -- -- --
Cash from Financing 128.71% 2,393.93% 2,204.22% 2,483.74% 3,211.96%
Foreign Exchange rate Adjustments 114.52% -- -415.60% -92.59% 45.61%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 97.74% 99.10% 68.40% 44.17% 25.11%